MetaCap

AbCellera Biologics (ABCL) News

NASDAQ: ABCLHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.69-0.78 (-7.45%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ABCL news summary

We found 4 recent headlines mentioning AbCellera Biologics (ABCL): 0 in the past week and 3 in the past 30 days, most often from Nasdaq, Business Wire. ABCL is making an outsized move today, down 7.45% at $9.69, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "AbCellera (ABCL) Q3 2026 Earnings Call Transcript", was published by Nasdaq on Nov 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest AbCellera Biologics headlines

Stocks mentioned alongside ABCL

Compare ABCL